Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
3.860
+0.130 (3.49%)
At close: Sep 11, 2026, 4:00 PM EDT
3.850
-0.010 (-0.26%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $7.44 million as of September 11, 2026. Its market cap has decreased by -26.42% in one year.
Market Cap
7.44M
Enterprise Value
11.46M
1-Year Change
-26.42%
Ranking
Category
Stock Price
$3.86
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $7.44M, a decrease of -98.92%. That is a compound annual growth rate of -55.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 7.44M | -29.15% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 8.17M |
| Alzamend Neuro | 8.15M |
| Imunon | 8.14M |
| Soligenix | 7.84M |
| Evogene | 7.81M |
| Acurx Pharmaceuticals | 7.38M |
| AIM ImmunoTech | 6.91M |
| CollPlant Biotechnologies | 6.69M |